31.07
Schlusskurs vom Vortag:
$29.30
Offen:
$29.39
24-Stunden-Volumen:
1.91M
Relative Volume:
1.58
Marktkapitalisierung:
$1.86B
Einnahmen:
$277.49M
Nettoeinkommen (Verlust:
$-192.14M
KGV:
-9.2455
EPS:
-3.36
Netto-Cashflow:
$-95.52M
1W Leistung:
+9.93%
1M Leistung:
-20.83%
6M Leistung:
-38.24%
1J Leistung:
-25.86%
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TWST
Twist Bioscience Corp
|
31.07 | 1.76B | 277.49M | -192.14M | -95.52M | -3.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
396.47 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.23 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
514.80 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
111.05 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
139.10 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
2024-06-04 | Eingeleitet | Guggenheim | Buy |
2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
2023-09-27 | Eingeleitet | Berenberg | Buy |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
2022-03-02 | Fortgesetzt | Cowen | Outperform |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-06-29 | Eingeleitet | William Blair | Outperform |
2021-06-04 | Eingeleitet | Goldman | Neutral |
2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Cetera Investment Advisers Invests $220,000 in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Gap Down to $28.2 on May 28 - GuruFocus
Twist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLC - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DE - Defense World
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Ameriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 5.14% on May 21 - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Bioscie - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Biosciences | TWST Stock News - GuruFocus
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions - Business Wire
Twist Bioscience stock hits 52-week low at $28.41 By Investing.com - Investing.com Canada
Twist Bioscience stock hits 52-week low at $28.41 - Investing.com
Twist Bioscience Corp (TWST) Stock Price Down 3.12% on May 19 - GuruFocus
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $50.40 - Defense World
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference - 01net
DNA Synthesis Market to Witness Growth from Synthetic Biology - openPR.com
Stifel Financial Corp Purchases 1,364 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience - Investing.com Nigeria
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience By Investing.com - Investing.com South Africa
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Leerink Partnrs Cuts Earnings Estimates for Twist Bioscience - Defense World
William Blair Issues Optimistic Outlook for TWST Earnings - Defense World
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
JPMorgan Chase & Co. Has Lowered Expectations for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
The Goldman Sachs Group Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Twist Bioscience (NASDAQ:TWST) Reaches New 52-Week Low After Earnings Miss - Defense World
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | - GuruFocus
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Cho Dennis | See Remarks |
May 21 '25 |
Sale |
29.75 |
531 |
15,796 |
105,318 |
Green Paula | SVP of Human Resources |
May 21 '25 |
Sale |
29.75 |
632 |
18,800 |
128,748 |
Finn Patrick John | President and COO |
May 21 '25 |
Sale |
29.75 |
1,877 |
55,835 |
240,783 |
Leproust Emily M. | Chief Executive Officer |
May 21 '25 |
Sale |
29.75 |
2,802 |
83,351 |
649,630 |
WERNER ROBERT F. | Chief Accounting Officer |
May 21 '25 |
Sale |
29.75 |
242 |
7,199 |
51,030 |
Laponis Adam | Chief Financial Officer |
May 21 '25 |
Sale |
29.75 |
936 |
27,843 |
106,018 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):